FRESH-PEF100-en
Assessment of cognitive function in children with growth hormone deficiency and children born small for gestational age
méMOTS
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Paediatrics | health theme |
| Endocrinology | health theme |
| Growth hormone deficiency | cim-11 |
| Biological determinants: Genetic predisposition | health determinant |
| Socio-demographic and economic determinants | health determinant |
| Biological determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Child, Preschool (2 to 5 years)","concept":{"vocab":"MeSH","vocabURI":"D002675"}},{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Child between the ages of 4 to 9 years, - Understanding French, - For whom the GH treatment was approved by a health insurance fund, - With an adequate supplementation of the other pituitary deficiencies in the case of a multiple deficiency.","clusion_E":""}
| Name |
|---|
| Sylvie;TROY |
| Name | Role |
|---|---|
| PFIZER (FRANCE) | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2007-01-01 | 2010-01-01 |
One-time cross-sectional study
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Sylvie;TROY | sylvie.troy@pfizer.com |